The novel therapy of the medication represents a major breakthrough in the management of the condition. Different to existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide985784.ezblogz.com/73875779/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment